ROY ANSHU MITTAL
No ORCID on file
· 30 papers in corpus
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…
2011
Disclosed herein is the use of a compound of formula (V), in particular Bithionol, wherein the substituents are as defined in the specification, in the manufacture of a medicament for inhibiting or reducing angiogenesis, inhibiting the grow…